구조모아 (StructureMoa)항암 chemical structure spider web
방문타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Super Hi-TCR-T cells (Super Hi-TCR-T cells) Eastern Hepatobiliary Surgery Hosp…·Advanced Hepatocellular Carcinoma … 1 trials |
|---|---|
Overview Program | Super Hi-TCR-T cells |
Overview Company | Eastern Hepatobiliary Surgery Hospital |
Overview Modality | CGT |
Overview Target | Advanced Hepatocellular Carcinoma (HCC) |
Overview Indication | Advanced Hepatocellular Carcinoma (HCC) |
Overview Phase | PHASE_2 |
Overview Status | RECRUITING |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Emerging |
Overview Approval status | Investigational |
Toxicology Major finding | Schlafen 11 (SLFN11) overexpression and nucleolar localization in response to bortezomib in multiple myeloma.. Proteins belonging to the Schlafen family are interferon-inducible and participate in the regulation of antiviral responses, immune signaling, and proteotoxic stress. SLFN11 kills cells with replicative damage, serving as a predictive biomarker for chemotherapeutic response. SLFN11 is epi… |
Clinical Safety signal | Schlafen 11 (SLFN11) overexpression and nucleolar localization in response to bortezomib in multiple myeloma.. Proteins belonging to the Schlafen family are interferon-inducible and participate in the regulation of antiviral responses, immune signaling, and proteotoxic stress. SLFN11 kills cells with replicative damage, serving as a predictive biomarker for chemotherapeutic response. SLFN11 is epi… |
Clinical Program phase | PHASE_2 |
타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Super Hi-TCR-T cells (Super Hi-TCR-T cells) Eastern Hepatobiliary Surgery Hosp…·Advanced Hepatocellular Carcinoma … 1 trials |
|---|---|
Overview Program | Super Hi-TCR-T cells |
Overview Company | Eastern Hepatobiliary Surgery Hospital |
Overview Modality | CGT |
Overview Target | Advanced Hepatocellular Carcinoma (HCC) |
Overview Indication | Advanced Hepatocellular Carcinoma (HCC) |
Overview Phase | PHASE_2 |
Overview Status | RECRUITING |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Emerging |
Overview Approval status | Investigational |
Toxicology Major finding | Schlafen 11 (SLFN11) overexpression and nucleolar localization in response to bortezomib in multiple myeloma.. Proteins belonging to the Schlafen family are interferon-inducible and participate in the regulation of antiviral responses, immune signaling, and proteotoxic stress. SLFN11 kills cells with replicative damage, serving as a predictive biomarker for chemotherapeutic response. SLFN11 is epi… |
Clinical Safety signal | Schlafen 11 (SLFN11) overexpression and nucleolar localization in response to bortezomib in multiple myeloma.. Proteins belonging to the Schlafen family are interferon-inducible and participate in the regulation of antiviral responses, immune signaling, and proteotoxic stress. SLFN11 kills cells with replicative damage, serving as a predictive biomarker for chemotherapeutic response. SLFN11 is epi… |
Clinical Program phase | PHASE_2 |
추천 비교
추천 비교